Antiretroviral regimens for HIV and HBV co-infection in patients receiving rituximab

Lancet Haematol. 2020 Dec;7(12):e857. doi: 10.1016/S2352-3026(20)30325-2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Coinfection* / drug therapy
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Hematologic Neoplasms*
  • Hepatitis B virus
  • Humans
  • Patients
  • Rituximab / adverse effects

Substances

  • Rituximab